BNT162b2 still effective, but less so, against Omicron
(HealthDay)—The effectiveness of two doses of BNT162b2 was maintained, albeit at a reduced level, during an omicron variant proxy period in South Africa, according to a letter to the editor published online Dec. 29 in the ...